Louis F J Slangen Net Worth

The estimated Net Worth of Louis F J Slangen is at least $269 Thousand dollars as of 30 April 2013. Louis Slangen owns over 1,000 units of Invacare stock worth over $24,087 and over the last 21 years Louis sold IVC stock worth over $244,990.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Louis Slangen IVC stock SEC Form 4 insiders trading

Louis has made over 9 trades of the Invacare stock since 2004, according to the Form 4 filled with the SEC. Most recently Louis bought 1,000 units of IVC stock worth $13,050 on 30 April 2013.

The largest trade Louis's ever made was exercising 33,200 units of Invacare stock on 4 November 2004 worth over $829,336. On average, Louis trades about 3,152 units every 125 days since 2003. As of 30 April 2013 Louis still owns at least 36,495 units of Invacare stock.

You can see the complete history of Louis Slangen stock trades at the bottom of the page.

What's Louis Slangen's mailing address?

Louis's mailing address filed with the SEC is , , , , .

Insiders trading at Invacare

Over the last 21 years, insiders at Invacare have traded over $3,551,958 worth of Invacare stock and bought 391,450 units worth $2,325,949 . The most active insiders traders include Edward F Crawford, Aaron Malachi Iii Mixon, and Steven H Azurite Management.... On average, Invacare executives and independent directors trade stock every 52 days with the average trade being worth of $10,700. The most recent stock trade was executed by Steven H Azurite Management... on 17 November 2022, trading 122,820 units of IVC stock currently worth $47,900.

What does Invacare do?

Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the Company designs, manufactures, and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The Company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The Company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The Company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia Pacific.

Complete history of Louis Slangen stock trades at Invacare

Invacare executives and stock owners

Invacare executives and other stock owners filed with the SEC include:

• Matthew Monaghan,
  Chairman of the Board, President, Chief Executive Officer
• Kathleen Leneghan,
  Chief Financial Officer, Senior Vice President
• Matthew E. Monaghan,
  Chairman, Pres & CEO
• Anthony LaPlaca,
  Senior Vice President, General Counsel, Secretary
• Ralf Ledda,
  Senior Vice President, General Manager - Europe, Middle East and Africa
• Anthony C. LaPlaca,
  Sr. VP, Gen. Counsel, Chief Admin. Officer & Sec.
• Kathleen P. Leneghan,
  Sr. VP & CFO
• Joost Beltman,
  Sr. VP & GM of North America
• Angela Goodwin,
  Sr. VP & Chief Information Technology Officer
• C. Martin Harris,
  Lead Independent Director
• Baiju Shah,
  Independent Director
• Clifford Nastas,
  Independent Director
• Susan Alexander,
  Independent Director
• Marc Gibeley,
  Independent Director
• Diana Ferguson,
  Independent Director
• Petra Danielsohn-Weil,
  Independent Director
• Julie Beck,
  Independent Director
• Lois Lee,
  Director, Treasury and Investor Relations
• Geoffrey P. Purtill,
  Sr. VP and GM of EMEA & APAC
• Geoffrey Purtill,
  Sr. VP and GM of EMEA & Asia Pacific
• Rick A. Cassiday,
  Sr. VP & Chief HR Officer
• Lois Lee CTP,
  Director of Treasury, Investor Relations & Corp. Comm.
• Stephanie L. Fehr,
  Director
• Steven H Azurite Management...,
  
• Rick A. Cassiday,
  SVP, Human Resources
• Michael J Merriman,
  Director
• Robert K Gudbranson,
  Senior VP and CFO
• Patricia A. Stumpp,
  Senior VP, Human Resources
• Dale C La Porte,
  Director
• Dean J. Childers,
  SVP & GM, North America
• Barbara W. Bodem,
  Director
• Darcie Karol,
  SVP, Human Resources
• Joost Beltman,
  Sr. VP and GM, North America
• Angie Goodwin,
  Chief Information Officer
• Joseph S Usaj,
  Senior VP - Human Resources
• Ellen O. Tauscher,
  Director
• John Remmers,
  Sr. VP Global Supply Chain&Eng
• Aaron Malachi Iii Mixon,
  Chairman and CEO
• Gerald B Blouch,
  President and COO
• Bridget A Miller,
  Vice President & Gen. Counsel
• Louis F J Slangen,
  Senior V.P.-Sales & Marketing
• Kenneth Sparrow,
  President-Invacare Europe
• Bernadine Healy,
  Director
• Diane J Davie,
  Senior VP - Human Resources
• James C Boland,
  Director
• Michael F Delaney,
  Director
• James L Jones,
  Director
• Danny O Driscoll,
  Managing Dir./Asia Pacific
• Joseph B Ii Richey,
  Senior Vice President
• William M Weber,
  Director
• Gregory C Thompson,
  Senior V.P. & CFO
• Dan T Iii Moore,
  Director
• Charles S. Robb,
  Director
• Carl E. Will,
  Sen. VP, Global Commercial Ops
• Franz Krammer,
  Mg. Dir. - Invacare Europe
• John Kasich,
  Director
• Whitney Evans,
  Director
• Neal J Curran,
  V.P.-Engineering & Prod. Dev.
• Matthew T Mullarkey,
  Vice President of Operations
• Gordon Sutherland,
  SVP & GM, EMEA
• Kempner Capital Management ...,
  
• Geoffrey Purtill,
  President and CEO
• Aron I Schwartz,
  Director
• Edward F Crawford,
  Director
• Steven H Rosen,
  Director